ROCHESTER—Officials of OptimizeRx Corp. (Nasdaq: OPRX), the provider of digital marketing messaging for the pharmaceutical industry, said the company is expected to join the Russell Microcap and Russell 3000 stock indexes at the conclusion of the 2019 Russell indexes annual reconstitution, effective after stock markets open in the United States on July 1, according to a preliminary list of additions posted June 21.
Membership in the Russell Microcap and 3000 indexes, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
“We are honored to be included in the Russell Indexes,” said OptimizeRx CEO William Febbo. “This marks a significant milestone in the growth and trajectory of our company, reflecting our record Q1 results, growing commercial team, and acquisition of CareSpeak. We expect our inclusion in these indexes to raise awareness of OptimizeRx across the investment community.”
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell’s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.
For more information on the Russell indexes reconstitution, see the “Russell Reconstitution” section on the FTSE Russell website.
OptimizeRx connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest point-of-prescribe promotional platform for the pharmaceutical industry, OptimizeRx provides a direct channel for pharma companies to communicate with healthcare providers within their workflow.
The cloud-based system supports patient adherence to medications with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest, and directly via its mobile communications platform.
More at www.optimizerx.com.